Skip to content
Search:
Search
Facebook page opens in new window
 
ADCS
Alzheimer's Disease Cooperative Study
ADCSADCS
  • About Us
    • About ADCS
    • Meet the Directors
    • ADCS Cores
    • ADCS Clinical Trials Network
    • ADCS Intervention Selection Committee
    • Steering Committee Voting Members
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Clinical Trials
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • CTMS
    • Clinical Conductor Enterprise
    • Clinical Conductor Site Portals
      • Donate
  • Steering Committee Members
  • Staff Resources
  • DONATE
  • About Us
    • About ADCS
    • Meet the Directors
    • ADCS Cores
    • ADCS Clinical Trials Network
    • ADCS Intervention Selection Committee
    • Steering Committee Voting Members
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Clinical Trials
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • CTMS
    • Clinical Conductor Enterprise
    • Clinical Conductor Site Portals
      • Donate
  • Steering Committee Members
  • Staff Resources
  • DONATE

Research News

You are here:
  1. Home

University of South Florida researchers quantify Alzheimer’s and other neuro diseases at $800 billion per year

Research NewsBy ADCS AdminMay 30, 2017

Read an overview of the substantial current and future economic impact of neurological disease, and an action plan for reducing this burden through neurological research and enhanced clinical management of neurological disorders in the US.

“When scientists saw the mouse heads glowing, they knew the discovery was big.”

Research NewsBy ADCS AdminMay 21, 2017

From WashPo for the layman, why we should be excited by the lymphatic system developments.  

Details

NIH Director Francis Collins’ blog on an antibody that potentially makes the tau protein detectable in blood

Research NewsBy ADCS AdminMay 2, 2017

A need exists for a simple, less-invasive test to diagnose Alzheimer’s disease and similar neurodegenerative conditions in living people, perhaps even before memory loss becomes obvious.

Exciting news in the hunt for novel AD-related biomarkers: Learn more about the “memory protein” – NPTX2

Research NewsBy ADCS AdminApril 28, 2017

Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. Here, we present findings supporting a special role for excitatory synapses connecting pyramidal neurons of the hippocampus and cortex with fast-spiking parvalbumin (PV) interneurons that control network excitability and rhythmicity.

Highlights from the ADPD conference last week in Vienna

Research NewsBy ADCS AdminApril 5, 2017

View the best moments of the 13th International Conference on Alzheimer’s & Parkinson’s Diseases. Mechanisms, Clinical Strategies, and Promising Treatments of Neurodegenerative Diseases

In depth coverage of AD/PD 2017 in the AlzForum series on the conference

Research NewsBy ADCS AdminApril 5, 2017

Held in the historic Austrian capital, the 13th AD/PD conference reflected a rapidly growing field. The meeting jammed science into five parallel sessions, with 545 talks running from early morning till late evening and some 1,200 posters vying for attention.

The JAMA publishes more “superager” data from the Northwestern University research team.

Research NewsBy ADCS AdminApril 4, 2017

Read “Rates of Cortical Atrophy in Adults 80 Years and Older With Superior vs Average Episodic Memory”

Read the Alzheimer’s Forum analysis of the new AD-genetic risk score developed by Rahul Desikan (UCSF), Ole Andreassen (University of Oslo), Anders Dale (UCSD) and colleagues.

Research NewsBy ADCS AdminMarch 24, 2017

In lieu of a crystal ball that can foresee Alzheimer’s, scientists are trying to divine impending disease by looking deep into a person’s genome.

The Alzheimer’s Association 2017 Facts and Figures is published!

Research NewsBy ADCS AdminMarch 2, 2017

Read the exceptional compilation of AD-related data and statistics. Includes a Special Report on the Next Frontier of Alzheimer’s Research

Maria Carrillo, PhD, Chief Science Officer, Alzheimer’s Association discussing government, industry and the Alzheimer’s Association collaborations in larger scale trials and innovative projects.

Research NewsBy ADCS AdminFebruary 23, 2017

As baby boomers age, an unprecedented number of people will be diagnosed with Alzheimer’s disease. The economic and social impacts will be wide reaching from cost of treatment to the effect on caregivers.

←12345…
67
8→
ADCS Research News
  • Home Based Assessments Trial Primary Paper in the Journal of Alzheimer’s & Dementia
  • “Young Latino’s Working in Alzheimer’s” Airs Tonight on UCSD TV and is Streaming on the Brain Channel
  • 40 Sites Across The Country To Test New Alzheimer’s Drug
  • Newly discovered Alzheimer’s genes lead to hope for future treatments
  • ADCS Director Howard Feldman, MD talks about the T2 Protect trial and a bright future for Alzheimer’s research
About ADCS
The Alzheimer’s Disease Cooperative Study (ADCS) was formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California San Diego.
Contact Us
  • E-mail:
    alzinfo@ucsd.edu
  • Phone:
    858-246-1333

Find us on:

Facebook page opens in new windowRss page opens in new windowMail page opens in new window
Location
Shipping Address:
9452 Medical Center Drive
4th Floor
La Jolla, CA 92037

Mailing Address:
9500 Gilman Dr
MC0949
La Jolla, CA 92093-0949
Copyright 2017 Regents of the University of California.
Go to Top